Skip to main content
. 2022 May 5;1:100010. doi: 10.1016/j.lansea.2022.04.006

Table 3.

Change in cancer service provision by study and patient pathway.

Author, Year Country Service of interest Control period Pandemic period Percentage change (95% CI)⁎⁎
Akhtar 2020 India Outpatient visits 20,822 7,973 -62
Inpatient admissions 2,840 1,184 -58
Surgical treatment provisions 598 410 -31
Pharmacological treatment 4,896 2,150 -56
Basu 2020 Bangladesh Diagnostic services 2018: 379,006
2019: 391,531
336,407 2018: -11.2
2019: -14.1
Das 2021 India Surgical treatment provisions 209 72 -66 (p<0.05)
Deshmukh 2021 India Surgical treatment provisions 929 28 -97
Pharmacological treatment 8,392 525 -94
Dewi 2021 Indonesia Outpatient visits 5,399 1,927 -35
Hewamana 2021 Sri Lanka Outpatient visits 1,059 977 -8 (6.2%, 9.5%)
Inpatient admissions 574 422 -26 (22.9%, 30.3%)
Kawthalkar 2021 India Diagnostic services 62 17 -72.6
Kumanan 2020 Sri Lanka Pharmacological treatment 342 274 -20
Mallick 2021 India Outpatient visits 5,291 5,090 -58
Pareek 2021 India Outpatient visits 4,363 895 -80
Pharmacological treatment 3,051 308 -90
Prajapati 2021 India Outpatient visits 235 69 -70
Surgical treatment provisions 132 66 -50
Ramakrishnan 2021 India Inpatient admissions 796 681 -14.4
Surgical treatment provisions 1,871 1,427 -23.7
Ranganathan 2021* India Outpatient visits 634,745 340,984 -46
Inpatient admissions 88,801 56,885 -36
Diagnostic services 398,373 246,616 -38
Surgical treatment provisions 17,120 8,677 -49
Pharmacological treatment 173,634 109,107 -37.5
Riju 2021 India Outpatient visits 5,904 549 -63
Inpatient admissions 288 35 -51.4
Surgical treatment provisions 192 26 -86
Sapkota 2021 Nepal Outpatient visits NR NR -80
Inpatient admissions 796 681 -50
Sharma 2021 India Outpatient visits 797 349 -56.3
Subbiah 2020 India Outpatient visits 4,096 2,602 -63.5
Inpatient admissions 749 462 -61.6
Surgical treatment provisions 1,972 1,115 -60

NR=not reported.

Study presents a range of service utilisation and disruption measures;

⁎⁎

Where available, p-values and confidence intervals reported.